Analyst Downgrades: Chimerix Inc, TrueCar Inc, and Best Buy Co Inc

Analysts downwardly revised their ratings and price targets on Chimerix Inc (NASDAQ:CMRX), TrueCar Inc (NASDAQ:TRUE), and Best Buy Co Inc (NYSE:BBY)

by Josh Selway

Published on Feb 19, 2016 at 10:05 AM
Updated on Feb 19, 2016 at 10:07 AM

Analysts are weighing in on biotech Chimerix Inc (NASDAQ:CMRX), auto pricing issue TrueCar Inc (NASDAQ:TRUE), and electronics retailer Best Buy Co Inc (NYSE:BBY). Here's a quick roundup of today's bearish brokerage notes on CMRX, TRUE, and BBY.

  • Citigroup this morning lowered its expectations on a bevy of biotech stocks, and for CMRX, this meant a price-target cut to $13 from $19. The stock is shrugging this off however, last seen 3.1% higher at $7.32, as it tries to recover some ground after its devastating bear gap back in December. The Street doesn't see this recovery going very far, though. Only 20% of brokerage firms recommend buying Chimerix Inc, and short interest now represents almost 13% of the stock's float -- after jumping over 80.6% in the last two reporting periods. 
  • TRUE is sliding this morning, giving back 18.4% at $4.71, after the company's current-quarter and full-year forecasts failed to live up to the Street's expectations. On top of this, TrueCar Inc's fourth-quarter numbers missed estimates. The shares have now lost almost half their value year-to-date, and analysts are losing hope. For instance, no fewer than seven dropped their price target on TRUE since yesterday's close, with JMP Securities lowering its opinion to "market perform" from "market outperform." Short sellers don't mind these losses, though. More than one-quarter of TRUE's float is sold short, and it'd take these bears almost 13 sessions to repurchase their positions, at average daily volumes. 
  • BBY is down 3.5% today at $29.68, after Goldman Sachs cut its rating on the stock to "neutral" from "buy," and removed it from its "America's Buy" list. However, the brokerage firm did raise its price target by $1 to $33. Looking to the options pits, put buying has hit an annual extreme compared to call buying at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). Specifically, Best Buy Co Inc's 10-day put/call volume ratio across these exchanges of 6.39 is higher than every other reading from the past 12 months. If the stock can right the ship on the charts -- and resume its bounce from its Jan. 15 annual low of $25.31 -- it could get a short-term boost should these bearish players hit the exits. 
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

a schaeffer's exclusive

PLAY TRENDS LIKE A PRO!

5 tips to leverage profits in this FREE insider report!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The IRS Loopholes Retirees Need to Know
Click to continue to advertiser's site.
Another Week of Fresh Highs Amid U.S.-China Trade Developments, Earnings
Developments on a trade deal between the U.S. and China were closely followed this week
Call Traders Blast These 2 Surging Stocks
Both stocks are enjoying record weeks
The IRS Loopholes Retirees Need to Know
Click to continue to advertiser's site.